Champlain Investment Partners’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,830,310
Closed -$59.2M 141
2025
Q1
$59.2M Sell
6,830,310
-288,326
-4% -$3.02M 0.43% 97
2024
Q4
$86.4M Buy
7,118,636
+8,106
+0.1% +$113K 0.55% 76
2024
Q3
$120M Buy
7,110,530
+690,029
+11% +$11.4M 0.72% 61
2024
Q2
$100M Buy
6,420,501
+859,630
+15% +$11.9M 0.62% 67
2024
Q1
$87.8M Sell
5,560,871
-36,920
-0.7% -$618K 0.5% 82
2023
Q4
$113M Buy
5,597,791
+1,208,769
+28% +$20.5M 0.67% 60
2023
Q3
$81.4M Buy
4,389,022
+298,052
+7% +$6.49M 0.53% 81
2023
Q2
$89M Buy
4,090,970
+1,000,700
+32% +$18.1M 0.55% 79
2023
Q1
$57.2M Buy
+3,090,270
New +$58.1M 0.36% 99

Other funds holding NEOG

Champlain Investment Partners's NEOG Position: Q2 2025 in Review

Champlain Investment Partners sold out of Neogen (NEOG) in Q2 2025, closing a stake of 6,830,310 shares — an estimated $59.2M sold.

Champlain Investment Partners first reported a position in NEOG in Q1 2023 and held it in 9 quarters. The position peaked at $120M in Q3 2024. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2025.

  • Champlain Investment Partners reported no remaining Neogen position as of Q2 2025 after selling out during the quarter.
  • Champlain Investment Partners sold 6,830,310 Neogen shares in Q2 2025, an estimated $59.2M.
  • Champlain Investment Partners first reported a position in Neogen in Q1 2023 and held it in 9 quarters.
  • Champlain Investment Partners's Neogen position peaked at $120M in Q3 2024.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q2 2025.

Based on Champlain Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.